Smith, Kline & French
E495721
Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.
All labels observed (2)
| Label | Occurrences |
|---|---|
| SmithKline | 2 |
| Smith, Kline & French canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T5125215 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Smith, Kline & French Context triple: [Sir James Black, employer, Smith, Kline & French]
-
A.
G. D. Searle & Company
G. D. Searle & Company was a major American pharmaceutical firm known for developing products such as the artificial sweetener aspartame (NutraSweet) before being acquired by Monsanto.
-
B.
Pharmacia
Pharmacia was a major pharmaceutical company known for its global drug development and manufacturing operations before ultimately becoming part of Pfizer.
-
C.
Upjohn Company
Upjohn Company was a prominent American pharmaceutical manufacturer founded in the 19th century, known for its innovations in drug formulation and its long-standing presence in Kalamazoo, Michigan.
-
D.
Schering
Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
-
E.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Smith, Kline & French Target entity description: Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.
-
A.
G. D. Searle & Company
G. D. Searle & Company was a major American pharmaceutical firm known for developing products such as the artificial sweetener aspartame (NutraSweet) before being acquired by Monsanto.
-
B.
Pharmacia
Pharmacia was a major pharmaceutical company known for its global drug development and manufacturing operations before ultimately becoming part of Pfizer.
-
C.
Upjohn Company
Upjohn Company was a prominent American pharmaceutical manufacturer founded in the 19th century, known for its innovations in drug formulation and its long-standing presence in Kalamazoo, Michigan.
-
D.
Schering
Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
-
E.
Merck & Co.
Merck & Co. is a major American pharmaceutical company known for developing and producing vaccines, oncology drugs, and other innovative medicines.
- F. None of above. chosen
Statements (32)
| Predicate | Object |
|---|---|
| instanceOf |
defunct company
ⓘ
pharmaceutical company ⓘ |
| activity |
clinical development
ⓘ
drug discovery ⓘ pharmaceutical marketing ⓘ |
| businessModel | research-based pharmaceutical company ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| eventualParentCompany | GlaxoSmithKline NERFINISHED ⓘ |
| field |
drug development
ⓘ
medical research ⓘ pharmacology ⓘ |
| hasSuccessorOrganization |
GlaxoSmithKline
NERFINISHED
ⓘ
SmithKline Beckman NERFINISHED ⓘ SmithKline Beecham NERFINISHED ⓘ |
| industry | pharmaceutical industry ⓘ |
| knownFor |
development of important prescription drugs
ⓘ
marketing of important prescription drugs ⓘ research in gastrointestinal drugs ⓘ research in psychopharmacology ⓘ |
| market | global prescription drug market ⓘ |
| mergedInto |
SmithKline Beckman
NERFINISHED
ⓘ
SmithKline Beecham NERFINISHED ⓘ |
| notableProduct |
Tagamet
NERFINISHED
ⓘ
Thorazine NERFINISHED ⓘ |
| partOf | SmithKline Beecham NERFINISHED ⓘ |
| productType |
pharmaceutical preparations
ⓘ
prescription drugs ⓘ |
| sector | healthcare ⓘ |
| status | defunct ⓘ |
| successor | GlaxoSmithKline NERFINISHED ⓘ |
| timePeriod | 20th century ⓘ |
| typeOfCompany | public company ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Smith, Kline & French Description of subject: Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.
Referenced by (3)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
SmithKline
this entity surface form:
SmithKline